Summit Creek Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Summit Creek Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$107.32 - $113.5 $148,208 - $156,743	-1,381 Reduced 32.0%	2,935 $320,000
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $49,974 - $91,153	-801 Reduced 15.65%	4,316 $491,000
Q3 2022 Nov 01, 2022	SELL	$58.92 - $84.67 $216,648 - $311,331	-3,677 Reduced 41.81%	5,117 $317,000
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $144,349 - $211,542	-1,818 Reduced 17.13%	8,794 $701,000
Q1 2022 May 09, 2022	BUY	$86.42 - $109.81 $94,975 - $120,681	1,099 Added 11.55%	10,612 $1.12 Million
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $1,872 - $2,278	19 Added 0.2%	9,513 $1.03 Million
Q3 2021 Nov 08, 2021	BUY	$91.91 - $110.37 $380,507 - $456,931	4,140 Added 77.33%	9,494 $1.04 Million
Q2 2021 Aug 04, 2021	BUY	$86.24 - $95.92 $181,104 - $201,432	2,100 Added 64.54%	5,354 $501,000
Q1 2021 Apr 20, 2021	BUY	$71.83 - $95.48 $233,734 - $310,691	3,254 New	3,254 $299,000
Q4 2020 Jan 20, 2021	SELL	$67.0 - $84.39 $217,080 - $273,423	-3,240 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$55.23 - $79.93 $178,945 - $258,973	3,240 New	3,240 $252,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Summit Creek Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Creek Advisors LLC with notifications on news.